This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Dividend for the Year 2023 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. agreed to acquire Baoding Shoujun Technology Co., Ltd. from Yao Lili, Zhang Xiaoqin and Tianjin Ruichuang Biotechnology Partnership (Limited Partnership) for CNY 230 million. CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023. CI
Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on October 27, 2023, has closed with 3,689,608 shares, representing 0.8% for CNY 59.99 million. CI
Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on October 27, 2023. CI
Tianjin Ringpu Bio-Technology Co.,Ltd. announces an Equity Buyback for CNY 80 million worth of its shares. CI
Tianjin Ringpu Bio-Technology Co.,Ltd. authorizes a Buyback Plan. CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Luzhu Biotechnology Ties Up With Tianjin Ringpu to Develop Pet Vaccines, Drugs MT
Beijing Luzhu Biotechnology Co., Ltd. and Tianjin Ringpu Bio-Technology Co., Ltd. Announces Strategic Cooperation Framework Agreement CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 08 June 2023 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for 2022 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. signed an agreement to acquire 15% stake in Fujian Sunvet Biotechnology Co., Ltd. from Guo Haiyan and 16 natural person shareholders for CNY 63 million. CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Executive Appointments CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Announces Cash Dividend of A Shares for 2021, Payable on 13 June 2022 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend for the Year 2021 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Proposes Dividend for Year 2021 CI
Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Chart Tianjin Ringpu Bio-Technology Co.,Ltd.
More charts
TIANJIN RINGPU BIO-TECHNOLOGY CO., LTD is a China-based company principally involved in the research, development, manufacture and sales of biological products and preparations for veterinary uses. The Company operates through two main segments. The Veterinary Use Biological Products segment is mainly involved in the manufacture and sales of poultry vaccines, veterinary use vaccines, biological products for treatment, diagnostic products and other biological products. The Veterinary Preparations segment is mainly involved in the manufacture and sales of chemical preparations, veterinary Chinese medicine and other preparations.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
15.95 CNY
Average target price
20.97 CNY
Spread / Average Target
+31.50%
Consensus
  1. Stock Market
  2. Equities
  3. 300119 Stock
  4. News Tianjin Ringpu Bio-Technology Co.,Ltd.
  5. Tianjin Ringpu Bio-Technology to Unlock Shares Issued in Grant Scheme